By competing with circulating androgens for binding sites on prostate cell receptors, antiandrogens promote apoptosis and inhibit prostate cancer growth.

Prostate cells that look normal under a microscope and are considered benign may be hiding genetic mutations that could develop into cancer, according to research.

Using secretomic analysis of prostate cell lines, one study was able to discover multiple proteins found in higher levels in the serum of cancer patients than in healthy controls.

Strategies which transport zinc into transformed prostate cells effectively eliminate these cells in animals.

Investigations have shown that cancerous prostate cells and prostate cells with low differentiation continue to produce and secrete prostasomes.